GLP-1 drugs do the following- Increase insulin production Reduce blood sugar Slow down digestion Reduce appetite What are GLP-1 drugs used for
Lixisenatide in Patients With Type 2 Diabetes and Acute Coronary Syndrome
The first GLP-RA, twice-daily exenatide, was approved in the USA in 2005 [3] and, most recently, semaglutide received approval for administration by injection in 2017 [4] and in an oral formulation in 2019 [5]
A balanced nutritional plan is key, emphasizing a diet rich in lean proteins, fiber, and healthy fats while limiting processed foods, sugary drinks, and refined carbohydrates
Performance of the method The modified GPx-DTNB method's performance was completed following the bioanalytical method validation guidelines set by the Committee for Medicinal Products for Human Use (Singh and Narsinghani 2023)
This restoration supports circadian alignment, balanced endocrine output, and rejuvenated cellular function, providing a physiological approach to age-related hormonal decline models